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Conditional lethal mutant(VACVWR062) is conserved in all members of the poxvirus family and encodes
a protein associated with the mature virion. We conﬁrmed this association and provided evidence for an
internal location. An inducible mutant that conditionally expresses E6 was constructed. In the absence of
inducer, plaque formation and virus production were severely inhibited in several cell lines, whereas some
replication occurred in others. This difference could be due to variation in the stringency of repression,
since we could not isolate a stable deletion mutant even in the more “permissive” cells. Under non-
permissive conditions, viral late proteins were synthesized but processing of core proteins was inefﬁcient,
indicative of an assembly block. Transmission electron microscopy of sections of cells infected with the
mutant in the absence of inducer revealed morphogenetic defects with crescents and empty immature
virions adjacent to dense inclusions of viroplasm. Mature virions were infrequent and cores appeared to
have lucent centers.
Published by Elsevier Inc.Introduction
Poxviruses are divided into chordopoxvirus and entomopoxvirus
subfamilies, which infect vertebrate and insect hosts, respectively
(Moss, 2007). Vaccinia virus (VACV), the prototype poxvirus, encodes
nearly 200 proteins of which approximately 100 are conserved in all
chordopoxviruses and about 50 of those can be identiﬁed in
entompoxviruses as well (Upton et al., 2003). The genes encoding
themajority of the highly conserved proteins are located in the central
portion of the VACV genome and encode structural components of the
virion and enzymes and factors needed for DNA replication and
transcription (Condit et al., 2006). The less conserved genes, located at
either end of the genome, encode a variety of proteins involved
primarily in host interactions (Nazarian and McFadden, 2006).
Although great progress has been made in characterizing VACV
genes, the roles of some such as E6R (VACVWR062) remain unknown.
E6, the protein encoded by the E6R open reading frame (ORF), is one
of about 80 that were identiﬁed in VACV mature virions by mass
spectrometry (Chung et al., 2006; Resch et al., 2007; Yoder et al.,
2006). In a recent study (Kato et al., 2008), three temperature-
sensitive mutants were mapped to the E6R open reading frame. We
have taken a combined genetic and biochemical approach toth, 33 North Drive, MSC3210,
formation, Bldg. 45, MSC 6510,
Inc.characterize the E6 protein. We provide evidence that E6 is a
component of the virion core and is essential for replication. When
expression of E6 was repressed, virion morphogenesis was severely
impaired at an early stage.
Results
Conservation of the E6R gene
The VACV E6R ORF is predicted to encode a protein of 567 amino
acids. A sequence alignment of E6 homologs from a representative of
each chordopoxvirus genus is presented in Fig. 1. Among the
orthopoxviruses, the sequence identity of E6 homologs is 98% or
greater. For other chordopoxviruses, the identity with VACV E6 is
between 44 and 63%. A putative homolog in the insect poxviruses
Amsacta moorei entomopoxvirus and Melanoplus sanguinipes ento-
mopoxvirus with approximately 18% sequence identity was detected
using the position-speciﬁc iterative protein–protein basic local
alignment search tool (psi-blastp) in the third iteration. To estimate
the signiﬁcance of the match, the Melanoplus sanguinipes entomo-
poxvirus sequence was shufﬂed 500 times and then each shufﬂed
sequence was aligned with VACV E6. No shufﬂed sequence reached
the score of the original alignments, allowing us to reject the null
hypothesis of no homology (pb0.002). The conclusion that E6 is
conserved in all poxviruses agrees with Upton et al. (2003). No
homology was detected with non-poxvirus proteins, nor were any
motifs suggestive of function or intracellular trafﬁcking found. The
nucleotides immediately upstream of the E6R ORF contain a variant
Fig. 1.Multiple alignments of amino acid sequences of chordopoxvirus E6 homologs. Identical and conserved amino acids are indicated by black and gray backgrounds, respectively.
Predicted alpha helix ( ) and β sheet (−−−) domains are indicated above the amino acid sequence. Abbreviations: VACV, vaccinia virus; LSDV, lumpy skin disease virus; YLDV,
Yaba-like tumour virus; MYXV, myxoma virus; SWPV, swinepox virus; MOCV, molluscum contagiosum virus; FWPV, fowlpox virus.
479W. Resch et al. / Virology 386 (2009) 478–485TAAAAATG with extra As of the consensus late promoter motif
TAAATG (Davison and Moss, 1989).
E6 is a component of the virion core
In order to detect the E6 protein, rabbits were immunized with a
conjugated peptide derived from amino acids 439 to 452 of the
predicted E6 amino acid sequence. Using the rabbit antiserum, a
protein of approximately 60 kDa was detected by Western blotting of
infected cell lysates at late times after infection. The presence of E6 in
puriﬁed MVs was conﬁrmed by Western blotting. The protein
remained in the insoluble pellet fraction after addition of NP40 and
dithiothreitol, similar to the core protein A3 and distinct from the
membrane protein A17 (Fig. 2). These data suggested that E6 is an
internal component of MVs.
Construction and infectivity of a recombinant VACV with an inducible
E6R gene
The conservation of the E6R gene made it likely that it would
be essential for virus replication. Therefore, we were not surprised
by the failure to isolate a stable mutant, in which the E6R genewas replaced with a gene encoding GFP, by homologous recombi-
nation in BS-C-1 cells. These results suggested that the E6 gene is
either essential or that deletion mutants are too enfeebled for
plaque isolation.
Our next approach to discerning the role of E6 was to make a
mutant that conditionally expresses the protein. An inducible
system based on the Eschericia coli lac operon was used (Ward et
al., 1995; Zhang and Moss, 1991a). In brief, a copy of the E6R gene
regulated by a bacteriophage T7 promoter was inserted into the
A56R (hemagglutinin) locus of the recombinant vT7lacOI, which
encoded the T7 RNA polymerase regulated by the late p11 VACV
promoter and the E. coli lac repressor regulated by a VACV early/
late promoter. Next, the original E6R gene was deleted and replaced
by the gene encoding GFP (Fig. 3A). Plaques containing recombinant
virus were recognized by their ﬂuorescence and the virus vE6Ri was
clonally puriﬁed in BS-C-1 cells by repeated plaque isolation in the
presence of inducer isopropyl-β-D-thiogalactopyranoside (IPTG).
Normal size plaques formed on a BS-C-1 monolayer in the presence
but not the absence of IPTG (Fig. 3B). By contrast, the parental
vT7lacOI virus formed similar size plaques in the presence or
absence of inducer. The IPTG requirement of vE6Ri to form plaques
could arise from decreased virus replication or spread. One-step
Fig. 2.Western blots of proteins extracted from puriﬁed virions. MVs were puriﬁed from
VACV-infected cells by sucrose gradient sedimentation and treated with NP40
detergent and dithithreitol (DTT) reducing agent as indicated by plus and minus
signs. Proteins were resolved by polyacrylamide gel electrophoresis, transferred to a
membrane and detected by chemiluminescence following incubation with primary
antibodies to E6, P4b/4b precursor and mature core proteins, and the A17 MV
membrane protein followed by a secondary antibody conjugated to horse radish
peroxidase. Abbreviations: S, soluble supernatant; P, insoluble pellet. Numbers on the
left indicate the mass in kDa and position of marker proteins.
Fig. 3. Structure and replication of a conditional lethal E6 mutant. (A) Diagram of
selected regions of the vE6Ri genome. Upper rectangles labeled E6R, J2R, and A56R are
ORFs used as sites of insertion of recombinant DNA. TK and HA, are abbreviations for
thymidine kinase and hemagglutinin, respectively. Lower rectangles show inserted DNA
encoding GFP; bacteriophage T7 RNA polymerase (T7pol) regulated by the late P11
promoter (P11) and lac operator (lacO); E. coli lac repressor (lacI) regulated by the
VACV p7.5 early/late promoter (P7.5); E. coli xanthine-guanine phosphoribosyltrans-
ferase (gpt) regulated by P7.5; and E6R regulated by the T7 promoter (PT7), lacO, and
encephalomyocarditis (EMC) cap-independent leader. (B) Plaque formation. BS-C-1
monolayers were infected with vE6Ri or the parent virus vT7lacOI in the presence (+)
or absence (−) of IPTG and incubated in normal growth medium supplemented with
1% methyl cellulose as a thickening agent. After 48 h, the cells were stained with crystal
violet. (C) IPTG-dependence of vE6Ri replication. BS-C-1 Cells were infected with 10
PFU per cell of vE6Ri (circles) or vT7lacOI (triangles) in the presence of indicated
concentrations of IPTG. At 24 h after infection, cells were harvested, lysed by three
freeze–thaw cycles and sonication. The virus titer was determined by plaque formation
on BS-C-1 monolayers in the presence of IPTG.
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tion. Virus replication in BS-C-1 cells increased up to 150-fold in
proportion with IPTG concentration and the maximum yield was
obtained at approximately 25 μM (Fig. 3C).
We tested a variety of cell lines to see if there were host
differences in the dependence on IPTG for replication of vE6Ri. Wild-
type plaques visualized by green ﬂuorescence formed in the presence
of IPTG in all cells tested, whereas in the absence of IPTG the plaques
were pinpoint in BS-C-1, RD, BHK-21, 3T3 and RK13 cells and
somewhat larger in HuTK-, HeLa and PCI-13 (Fig. 4 and data not
shown). In view of the possibility that the latter cell lines would be
more permissive for an E6R deletion mutant, we tried another
isolation strategy. The E6R gene was deleted from the VACV genome
in a bacterial artiﬁcial chromosome (Domi and Moss, 2002, 2005).
Attempts to rescue infectious VACV lacking E6R in PCI-13 or HuTK−
cells were unsuccessful, however, whereas rescue of a VACV bacterial
artiﬁcial chromosome containing intact E6R was accomplished in
parallel transfections (data not shown). It seems likely, therefore,
that the difference in IPTG dependence resulted from less stringent
repression of E6 in some cells rather than a true host-range effect.
However, our antibody was not sufﬁciently sensitive and free of
cross-reactivity to detect low expression.
Synthesis and processing of viral late proteins
Further experiments were carried out in BS-C-1 or BHK-21 cells
because of their stringent repression of replication. At 9 h after
infecting BS-C-1 cells with vE6Ri or the parental vT7lacOI in the
presence or absence of IPTG or the drug rifampicin, lysates
prepared from pulse-labeled cells were analyzed by SDS poly-
acrylamide gel electrophoresis and autoradiography. The well-
characterized pattern of radioactivity indicated that viral late
protein synthesis proceeded similarly in the presence or absence
of IPTG (Fig. 5). Several viral proteins undergo proteolytic
processing during virus maturation, and this can be prevented by
the drug rifampicin (Katz and Moss, 1970; Moss and Rosenblum,
1973). Following a chase with non-radioactive amino acids, the
pattern of radioactivity indicated diminished processing of the
precursors of the 4A (A10) and 4B (A3) proteins, although this was
not as severe as with rifampicin (Fig. 5).Western blotting was used to conﬁrm the defect in protein
processing. Cells were infected with vE6Ri in the presence or absence
of IPTG and samples removed at intervals between 0 and 48 h.
Following gel electrophoresis, the proteins were transferred to a
membrane and probed with speciﬁc antibodies to the 4B core and A17
membrane proteins. In the presence of IPTG, processing of the 4B and
A17 precursors were detected at 8 h after infection and by 24 h the
processed proteins exceeded the amount of precursor (Fig. 6). In the
absence of IPTG, processing of the 4B precursor was undetectable at
8 h and detectable only as faint bands at 12 and 24 h but increased by
48 h. Processing of the A17 membrane protein, which is not inhibited
by rifampicin (Betakova et al., 1999b; Rodriguez et al., 1993), was only
mildly affected by E6 repression (Fig. 6). These data suggested a defect
at a post-membrane formation stage in virion morphogenesis.
Fig. 4. Host cell effect on plaque formation. Monolayers of BS-C-1, RD, HuTK-, HeLa and
PCI-13 cells were infectedwith vE6Ri in the presence (+) or absence (−) of 25 μM IPTG.
After 24 h, the cells were examined under a ﬂuorescence microscope and images of
individual typical plaques are shown. Scale bars correspond to 0.1 mm.
Fig. 5. Effect of E6 repression on synthesis and processing of viral late proteins. BS-C-1
cells were infected with vE6Ri or vT7lacOI in the presence or absence of 25 μM IPTG or
100 μg/ml of rifampicin (Rif). At 9 h after infection, the cells were pulse-labeled (P)
with [35S]methionine and [35S]cysteine for 30 min in methionine-and cysteine-
deﬁcient medium. The cells were then washed and incubated in regular medium for
15 h as a chase (C). Cell lysates were prepared and the proteins were separated on a SDS
4 to 12% polyacrylamide gradient gel. An autoradiogram is shown. The positions of the
core proteins 4a and 4b and their precursors P4a and P4b are indicated on the right. The
masses in kDa and positions of marker proteins are shown on the left.
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Thin sections of BS-C-1 cells infectedwith vE6Ri in the absence and
presence of IPTGwere examined by transmission electronmicroscopy.
In the presence of IPTG, circular IVs with granular material, MVs with
well-deﬁned cores, and membrane wrapped virions were abundant
(Fig. 7B). In the absence of IPTG, many crescents and IVs with and
without internal granular material were adjacent to dense inclusions
not seen in the presence of inducer and some round, dense virions
were also present (Fig. 7A). Brick-shaped MVs and WVs were
infrequent and the cores usually had a lucent appearance (Fig. 7A).
The differences between cells infected in the presence (A, C, E) and
absence (B, D, F) of IPTG were more clearly seen in the higher power
images in Fig. 8. Similar images were also found on examination of
BHK-21 cells infected with vE6Ri in the absence of IPTG (not shown).
Discussion
Using a speciﬁc antibody for Western blotting, we conﬁrmed the
association of E6 with puriﬁed MVs, which had previously been
determined by mass spectrometry (Chung et al., 2006; Resch et al.,
2007; Yoder et al., 2006). Our inability to extract the protein in asoluble form by incubating puriﬁed MVs with NP40 and reducing
agent suggested that E6 is an internal component of the MV. Such
insolubility was the major criterion used to assign 47 other VACV
proteins to the core or lateral body (Condit et al., 2006). Of these
internal proteins, 19 are like E6 in having no known or predicted
enzymatic function and are presumed to have structural roles. Our
attempts to isolate a viable E6 deletion mutant failed, leading us to
construct a recombinant virus in which the E. coli lac operator
regulated E6 expression. In the absence of inducer, plaque formation
and virus yield were severely inhibited in several cell lines including
monkey BS-C-1, rabbit RK13, hamster BHK-21, mouse 3T3 and human
RD cells. However, in the absence of inducer replication occurred to
varying degrees in human HuTK-, HeLa and PCI-13 cells. Initially, we
considered that E6 might be a host range factor. However, we were
unable to rescue a VACV bacterial artiﬁcial chromosome with an E6
deletion in either HuTK-or PCI-13 cells. It seems likely that low
amounts of E6 allow limited replication and that the repression is
incomplete in the more permissive cell lines. However, our antibody
was not sufﬁciently sensitive or free of non-speciﬁc binding to test this
possibility. Therefore, we proceeded to use BS-C-1 and BHK-21 cells to
study the replication defect.
Amino acid labeling studies indicated that E6 was not required for
late gene expression. However, the proteolytic processing of core
proteins 4a and 4b was inhibited. By contrast, processing of the A17
membrane proteinwas much less affected. Although the I7 protease is
responsible for cleavage of several core proteins and the A17
membrane protein (Ansarah-Sobrinho and Moss, 2004; Byrd et al.,
2003), the latter is less dependent on morphogenesis and is not
blocked by rifampicin (Betakova et al., 1999b; Rodriguez et al., 1993),
which prevents the association of the D13 scaffold withmembranes to
form crescent structures (Moss et al., 1969; Szajner et al., 2005; Zhang
and Moss, 1992).
Fig. 6. Effect of E6 repression on the synthesis and processing of representative core and
membrane proteins determined by Western blotting. BS-C-1 cells were infected with
vE6Ri in the absence (−) or presence (+) of 25 μM IPTG. At indicated times between 0
and 48 h, lysates were prepared and the proteins resolved by gel electrophoresis as
described in the legend to Fig. 5. The proteins were transferred to a membrane and
probed with rabbit polyclonal antiserum to the 4b core protein or A17 membrane
protein followed by anti-rabbit immunoglobulin G conjugated to horseradish
peroxidase. The proteins were visualized by chemiluminescence. The positions of
precursor 4b (P4b) and processed 4b and of full length (ﬂ) A17 and C-terminal
processed (c) A17 are indicated on the right. The masses in kDa and positions of marker
proteins are shown on the left.
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in morphogenesis that corresponded with the protein processing
data. Although crescent membranes and IVs were visualized, they
were frequently adjacent to dense inclusions of viroplasm, which
contain the core proteins. In addition, many of the IVs appeared
empty because of the absence of enclosed viroplasm and MVs were
sparse and many appeared defective. With regard to the inclusions,
the phenotype resembled that obtained with the conditional lethal
A15, A30, D2, D3, G7 and J1 mutants, which interact to form a
complex (Chiu et al., 2005; Mercer and Traktman, 2005; Szajner et
al., 2003, 2004a, 2004b, 2001). However, with the latter mutants,
the IVs appear more uniformly empty and MVs do not form,
whereas many IVs did contain viroplasm in cells infected with the
E6 mutant and there were abnormal MVs. Abnormal MVs that
appear more spherical or have internal defects are found with
mutations of some other non-enzymatic core proteins (Heljasvaara
et al., 2001; Kato et al., 2004; Klemperer et al., 1997; Williams et al.,
1999; Zhang and Moss, 1991b).
Kato et al. (2008) recently mapped three temperature sensitive
mutants, including Dts41 (#6606) and Dts80 (#9021) from the S.
Dales collection, to the E6R gene. Both Dts41 and Dts80 were
described as having defects in morphogenesis at the non-
permissive temperature (Dales et al., 1978). Electron micrographs
of cells infected with these mutants were not published; instead
the mutants were placed in morphogenetic classes and only
images of other representatives of these classes were shown. The
morphogenetic classes go from A to Q, in order of increasing
development e.g. A has no virus structures and Q has normal
looking IVs and MVs. Of these, the representative image shown of
an F class mutant seems to most resemble vE6Ri in the absence
of IPTG, as both contain masses of viroplasm and empty IVs.
Dts80, however, was placed in the H class and the representative
image for this group has no empty IVs, although masses of
viroplasm are present. The Dales H class is deﬁned as a composite
of classes D–F so there may be some variation in the individual
mutants placed in this class and the phenotype of Dts80 may
have additional similarities or differences relative to vE6Ri. Dts80
was also subclassiﬁed as Q, indicating some normal-looking
virions. Dts41 was classiﬁed as having a P phenotype, which is
deﬁned as normal-looking immature particles and mature parti-
cles with cores that are predominantly lucent at the center.
Although we did ﬁnd mature particles with lucent centers in cells
infected with vE6Ri in the absence of IPTG, the more obviousdefects were at early stages. It is certainly possible that
temperature sensitive and inducible null mutants will exhibit
phenotypic differences. However, direct comparisons using the
same strains of virus, cell lines and microscopic procedures are
needed to make unambiguous conclusions.
Materials and methods
Cell lines and virus strains
BS-C-1 (African green monkey kidney cells; ATCC:CCL-26), RD
(human rhabdomyosarcoma cells; ATCC:CCL-136), HuTK−143 (non-
producer human cells induced by murine sarcoma virus; (Rhim et
al., 1975), HeLa (human adenocarcinoma celss; ATCC:CCL-2), and
PCI-13 (human pharyngeal carcinoma cells) cells were maintained
under standard culture conditions. The Western Reserve (WR)
strain of VACV and the vT7lacOI recombinant (Alexander et al.,
1992) were propagated as described previously. vE6Ri was
propagated in the presence of 25 μM IPTG.
Antibodies
Rabbit antiserum was raised against a peptide derived from the
predicted E6 amino acids 439 to 452 (KKLSSIKSKSRRLN) plus a C-
terminal cysteine added for coupling to keyhole limpet hemocya-
nin (Covance Research Products, Denver, PA). Anti-A17-N (Beta-
kova et al., 1999a) and anti-A3 (P4b/4b) (Resch et al., 2005) rabbit
antisera were described previously.
Plasmid and recombinant VACV construction
To construct pVOTE-E6R, the E6R ORF was ampliﬁed by PCR
from genomic DNA using the oligonucleotide primers 5′-GTA TTA
CCT GCA TAC CAT GGA TTT TAT TCG TAG AAA GT-3′ and 5′-CTA
TGA TCT ACC GTG TCT TAT CAA TTG AAG TAT-3′, and the PCR
product was inserted within the NcoI–SmaI sites of pVOTE.1
downstream of an encephalomyocarditis virus leader sequence
(Ward et al., 1995). This plasmid was used to introduce the
repressible copy of E6R into the hemagglutinin (A56R) locus of
vT7lacOI by homologous recombination and mycophenolic acid
selection as described previously (Ward et al., 1995), resulting in
the intermediate virus vE6R/E6Ri. The presence of the inducible
E6R copy was veriﬁed by PCR ampliﬁcation and sequence analysis.
The endogenous E6R ORF was replaced with the GFP marker gene
by homologous recombination with a linear DNA fragment
containing the GFP sequence fused to E6R-ﬂanking sequences.
This fragment was generated in three steps. First, three indepen-
dent PCR ampliﬁcations were carried out to amplify the ﬂanking
regions and the GFP sequence. The upstream ﬂanking region was
ampliﬁed with the oligonucleotide primers 5′-TCT TTA TCA AAC
AGA TGG TAG AAC AAT GTG TGA CAT CCC-3′ and 5′-TTG CTC ACC
ATT TTT ATA GAA GAG AGT TAT CTA TGA TAC-3′. The GFP sequence
was ampliﬁed with oligonucleotide primers 5′-TCT CTT CTA TAA
AAA TGG TGA GCA AGG GCG AGG AGC TG-3′ and 5′-ATA TTT GGT
CTG TTT TAT CTA GAT CCG GTG GAT CCC GGG C-3′. The lower
ﬂanking region was ampliﬁed by using the oligonucleotide primers
5′-GGA TCT AGA TAA AAC AGA CCA AAT ATA TTA TTA ATA ATT T-3′
and 5′-AGA GTT GTT CTA GCA TCC ATT CAT TGT CTT TAC ATC CGT
T-3′. The separate products were combined using their terminal
overlaps in a ﬁnal PCR reaction using the outer forward and
reverse primers. The ﬁnal PCR product was transfected into cells
infected with vE6R/E6Ri at 0.5 PFU per cell using Lipofectamine
2000 (Invitrogen). Recombinant viruses expressing GFP were
isolated by ﬁve rounds of plaque puriﬁcation using an inverted
ﬂuorescence microscope. The correct site of recombination was
veriﬁed by PCR analysis.
Fig. 7. Low magniﬁcation transmission electron microscopic images of cells infected with vE6Ri. BS-C-1 cells were infected with vE6Ri in absence (A) or presence (B) of 25 μM IPTG
and ﬁxed after 24 h. Magniﬁcation is indicated by the bar at the bottom of panel B. Abbreviations: AV, aggregated viroplasm; CR, crescent, IV, immature virion, MV, mature virion;WV,
wrapped virion, EV, enveloped virion; mito, mitochondrion.
483W. Resch et al. / Virology 386 (2009) 478–485Western blot analysis
Proteins of MV particles, puriﬁed by sucrose gradient centrifu-
gation (Earl and Moss, 1998), or infected cell lysates were resolved
by SDS-polyacrylamide gel electrophoresis on 4 to 12% gradient
SDS-polyacrylamide gels with 3-(N-morpholino)propanesulfonic
acid running buffer (Invitrogen) and electrophoretically transferred
to nitrocellulose membranes. Nonspeciﬁc binding sites were
blocked with 5% nonfat dried milk or 5% bovine serum albumin
in Tris-buffered saline. The membranes were probed with rabbit
polyclonal antiserum, followed by anti-rabbit immunoglobulin Gconjugated to horseradish peroxidase. Bound antibody was
detected by chemiluminescence with commercial reagents (Pierce,
Rockford, IL).
Pulse-labeling of proteins with [35S]methionine and [35S]cysteine
BS-C-1 cells were incubated with 5 PFU of virus per cell for 1 h at
37 °C. After adsorption, cells were washed three times and incubated
at 37 °C in Eagle modiﬁed essential medium supplemented with 2.5%
fetal bovine serum in the presence or absence of 25 μM IPTG. At
30 min before labeling, the medium was replaced with cysteine-and
Fig. 8. High magniﬁcation electron microscopic images of cells infected with vE6Ri. Infection was carried out in presence (A, C, E) or absence (B, D, F) of IPTG as described in the
legend to Fig. 7. Fields containing mostly IVs (A, B), MVs (C, D) and EVs (E, F). Abbreviations are the same as in the legend to Fig. 7. Magniﬁcation is indicated in bar near lower right
corner of each image.
484 W. Resch et al. / Virology 386 (2009) 478–485methionine-free medium, and cells were incubated for 30 min at
37 °C, followed by the addition of 100 μCi of a mixture of [35S]
methionine and [35S]cysteine per ml of deﬁcient medium. After
30 min, some cells were harvested and others were washed with
regular medium and incubated for an additional 15 h. Harvested cells
were washed once with cold phosphate-buffered saline and whole-
cell lysates were prepared in 1× sample buffer (Invitrogen). Samples
were separated on an SDS 4 to 12% polyacrylamide gradient gel with
3-(N-morpholino)propanesulfonic acid running buffer (Invitrogen).
Transmission electron microscopy
BS-C-1 cells were grown in 60-mm-diameter dishes and infected
with 3 PFU per cell of vE6Ri in the presence or absence of 25 μM IPTG.
At 24 h after infection, cells were ﬁxed and prepared for transmission
electron microscopy as described previously (Senkevich et al., 2008).Acknowledgments
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